Form 8-K - Current report:
SEC Accession No. 0001437749-17-011906
Filing Date
2017-06-28
Accepted
2017-06-28 16:08:43
Documents
21
Period of Report
2017-06-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20170627_8k.htm 8-K 33215
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 21503
3 EXHIBIT 99.2 ex99-2.htm EX-99.2 11997
4 a16.jpg GRAPHIC 44981
5 a15.jpg GRAPHIC 44871
6 a14.jpg GRAPHIC 81227
7 a13.jpg GRAPHIC 112754
8 a12.jpg GRAPHIC 78398
9 a11.jpg GRAPHIC 154550
10 a10.jpg GRAPHIC 169785
11 a9.jpg GRAPHIC 161894
12 a8.jpg GRAPHIC 135054
13 a7.jpg GRAPHIC 82150
14 a6.jpg GRAPHIC 64443
15 a5.jpg GRAPHIC 77236
16 a4.jpg GRAPHIC 165616
17 a3.jpg GRAPHIC 127616
18 a2.jpg GRAPHIC 210266
19 a1.jpg GRAPHIC 44871
20 ex99-1img002.jpg GRAPHIC 3740
21 ex99-1img001.jpg GRAPHIC 2054
  Complete submission text file 0001437749-17-011906.txt   2495724
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 17935324
SIC: 2834 Pharmaceutical Preparations